VC

Vericel

- NASDAQ:VCEL
Last Updated 2024-04-26
  • Vericel Corporation | Expanded Cellular Therapies | CLI And DCM Clinical Research

  • Total Funding (USD)

    114.8 million

  • Security

    Type: ORD
    CUSIP: 92346J108
    ISIN: US92346J1088
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo